Pharmaceutical composition and kit for treating bacterial infections
US9381201B2 · kind B2 · utility
Inventors
Key dates
| Filing date | Oct 25, 2012 |
| Grant date | Jul 5, 2016 |
| Priority date | — |
| Expiry date | Dec 1, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmacology and medicine, more particularly to novel pharmaceutical compositions and pharmaceutical kits for treating bacterial infections, and to novel method for treating diseases caused by bacterial infections including tuberculosis. The pharmaceutical composition is disclosed comprising Rifamycin and interferon inducer in pharmacologically effective doses, and also pharmaceutical kit for treating diseases caused by bacterial and healthcare acquired infections, comprising pharmacologically effective doses of Rifamycin in the form of a tablet, a capsule or an injection, interferon inducer in the form of a tablet, a capsule or an injection, and instruction for administration of the components of this pharmaceutical kit.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.